Home > Media KIt > News Room

Unaudited Financial Results For the Quarter ended 31st December, 2011
(Rs. in Lacs)
S.No. Particulars Quarter ended 9 Months Ended Year ended
31.12.2011 30.09.2011 31.12.2010 31.12.2011 31.12.2010 31.03.2011
(Unaudited) (Unaudited) (Audited)
1 Gross Sales/Income from Operations           7,236           6,181         5,496         19,507       16,216         21,794
  Less: Excise Duty   131              53              65              254            202              311
(a) Net Sales/Income from Operations           7,105   6,128         5,430         19,253       16,014         21,483
(b) Other Operating Income                  6        3                1                11                5              252
  Total Net Operating Income (1a+1b)           7,110           6,131         5,431         19,264       16,019         21,735
2 Expenditure              
  a)  (Increase) / Decrease in Stock-in-Trade & Work in Progress            (123) 51            144            (209)           (259)            (340)
  b)  Consumption of Raw Materials           3,483           2,607         2,106           9,763         7,371         10,498
  c)  Purchase of traded goods           1,382           1,165         1,412           3,272         3,613           4,494
  d)  Employee Cost              827              808            683           2,400         1,996           2,728
  e) Depreciation and Amortisation           1,139           1,216         1,163           3,496         3,458           4,578
  f)  Other Expenditure           1,091              998            934           3,033         2,676           3,526
  Total Expenditure             7,800           6,845         6,443         21,755       18,854         25,485
3 Profit / (Loss) from Operations before Other Income, Interest and Exceptional Items (1-2)            (689)            (715)        (1,011)         (2,491)        (2,835)         (3,750)
4  Other Income                   -                  -                 -                  -                 -                  -  
5 Profit / (Loss) before Interest and Exceptional Items (3+4)            (689)            (715)        (1,011)         (2,491)        (2,835)         (3,750)
6  Interest                  216              210            143              649            458              623
7 Profit / (Loss) after Interest but before Exceptional Items (5-6)            (906)            (924)        (1,154)         (3,140)        (3,293)         (4,373)
8 Exceptional Items - Income/(Expense)                -                  -                 -                  -                 -                  -  
9 Profit / (Loss) from Ordinary Activities before Tax (7-8)            (906)            (924)        (1,154)         (3,140)        (3,293)         (4,373)
10 Tax Expense               
  - Provision for Earlier Year                -                  -                 -                  -                 -                (75)
11 Profit / (Loss) from Ordinary Activities after Tax (9-10)            (906)            (924)        (1,154)         (3,140)        (3,293)         (4,298)
12 Extraordinary Items-Income/(Expense)                -                  -                 -                  -                 -                  -  
13 Net Profit /(Loss) for the period (11-12)            (906)            (924)        (1,154)         (3,140)        (3,293)         (4,298)
14 Paid-up Equity Share Capital of Face Value of Rs.2/- each           8,996           8,996         8,996           8,996         8,996           8,996
15 Reserves excluding Revaluation reserves                -                  -                 -                  -                 -           16,765
16 a) Earning Per Share before Extraordinary Items (in Rs.)            
  - Basic & Diluted           (0.20) (0.21) (0.26)           (0.70) (0.73) (0.96)
  b) Earning Per Share after Extraordinary Items (in Rs.)            
  - Basic & Diluted           (0.20) (0.21) (0.26)           (0.70) (0.73) (0.96)
17 Public Shareholding            
  - Number of Shares 294454615 294454615 294454615 294454615 294454615 294454615
  - Percentage of shareholding 65.46% 65.46% 65.46% 65.46% 65.46% 65.46%
18 Promoters and Promoter Group Shareholding            
  a) Pledged / Encumbered            
  - Number of Shares 610000 610000 610000 610000 610000 610000
  - Percentage of shares (as a % of the total shareholding of promoter and promoter group) 0.39% 0.39% 0.39% 0.39% 0.39% 0.39%
  - Percentage of shares (as a % of the total share capital of the company) 0.14% 0.14% 0.14% 0.14% 0.14% 0.14%
  b) Non-encumbered            
  - Number of Shares 154761588 154761588 154761588 154761588 154761588 154761588
  - Percentage of shares (as a % of the total shareholding of promoter and promoter group) 99.61% 99.61% 99.61% 99.61% 99.61% 99.61%
  - Percentage of shares (as a % of the total share capital of the company) 34.40% 34.40% 34.40% 34.40% 34.40% 34.40%
Notes:
  1. The above results were reviewed by the audit committee and have been approved by the Board of Directors in the meeting held on 10th February, 2012. A limited review of the same had been carried out by the statutory auditors.
  2. The Company's business activity falls in single primary business segment i.e.Pharmaceuticals.
  3. Consolidated Income from Operatitons, Profit / (Loss) after tax and EPS for the quarter ended 31st December, 2011 stands at Rs. 7716 Lacs,  Rs.(815) Lacs & Rs. (0.18) respectively.
  4. There were no investor complaints pending at the beginning of the quarter. During the quarter 4 shareholder's complaints were received & resolved.
  5. Figures for the previous year / quarter are re-arranged, wherever necessary, to conform to the figures for the current quarter.
               
        For and on behalf of the Board
               
Place : New Delhi
Date : 10.02.2012		   (Sushil Suri)
Chairman & Managing Director